Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (951)	12/14/2001 11:24:44 AM
From: tuck	Read Replies (1) \| Respond to of 1784

Bruker AXS (BAXS) IPO'd today, $1.50 below the low end of the initial $8 - $10 range. This is the first pure play in X-Ray Crystallography available to the trading public, and boy, are we grateful. We'd be really excited if these companies (Emerald BioStructures (MCLS), Syrrx, Structural BioInformatics, etc.) could make deals for royalties, but I've found none so far. Putting it in the WatchList. It will also be covered on BLUE HP. Meanwhile, browsing around, found this overview of microarray readers, which mentions a number of companies Trickle owns or follows: the-scientist.com Trickle highly recommends reading these LabConsumer Archives to get an idea of the various trickle markets. Cheers, Tuck